4-BROMO-2-IODO(TRIFLUOROMETHOXY)BENZENE, 95.0%, 25g

N,N'-Ethylenebisoctadecanamide (mixture of fatty acid amides) (consists of C14, C16 and C18)>85.0%(GC)25g

DL-�-(p-Bromophenyl)alanine, 97.0%, 5g

5-Bromo-2-(difluoromethyl)-1-fluoro-3-methoxybenzene, 98%, 1g

DIETHYL 2-(5-METHYLPYRIDIN-2-YL)MALONATE, 95.0%, 250mg

5-((tert-Butyldimethylsilyl)oxy)-3-iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, 98%, 100mg

8-chloro-4-phenylsulfanyl-1-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]quinoxaline, 97%, 50mg

1,2,4-Trihydroxy-9,10-anthracenedione, 95.0%, 1g

1-Boc-4-Ethynylpiperidine, 95.0%, 100mg

5-Bromoindole-2-carboxylic acid, 95.0%, 1g

Isoquinolin-7-yl-7-boronic acid, 95.0%, 250mg

N,N-Dimethyl-1H-pyrazole-1-sulfonamide, 95.0%, 5g

Fmoc-L-Cysteine-(Trityl), PEPTIPURE®, min. 98.5%, for biochemistry, 25 g, glass packaging